The shareholders approved the dividend on equity shares for the FY: 2024-25 @ Re. 1/- per share of Rs. 10 each (10%)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 33rd Annual General Meeting held on September 25, 2025, shareholders of Samrat Pharmachem Ltd approved a dividend of Re. 1 per equity share on a face value of Rs. 10 each, translating to a 10% dividend. The AGM was conducted through video conferencing/other audio-visual means. The disclosure was made to BSE pursuant to SEBI Listing Regulations, signed by the Company Secretary Nishant Kankaria on September 27, 2025.
This is a modest, standard dividend payout for shareholders. Since only the face-value percentage (10%) is disclosed and the market price is not provided, the effective dividend yield cannot be determined from this filing alone. The announcement confirms continuity in shareholder returns but is unlikely to be a major stock-moving event.